Abstract
New alternatives to growth factors, such as transforming growth factor beta (TGF-β), epidermal growth factor (EGF), fibroblast growth factor (FGF) and bone morphogenetic proteins (BMP), for wound healing have been devised and investigated to maintain their biological properties, as well as to reduce their complicated adverse effects. In this study, we have focused on OP10 peptide modified from BMPs which regulates a variety of cellular processes, such as proliferation, differentiation, bone/cartilage morphogenesis, apoptosis, and wound healing. The wound healing process involves multiple physiological processes, such as proliferation and migration of dermal fibroblasts and epidermal keratinocytes. These processes play an important role in collagen production and the regulation of elastin levels in dermal tissue regeneration. In order to evaluate the promotion of cell proliferation and migration using OP10, MTT and scratch assays were carried out using normal dermal human fibroblast (NHDF). OP10 promoted proliferation and migration of NHDFs similar to those found with FGF. OP10 was focused on this study and was further investigated for its wound skin regeneration capacity and compared to FGF, by mRNA and protein expression. OP10 was found to increase the protein expression of procollagen and the mRNA level of Type I collagen, to levels similar or even higher than that found with FGF. OP10 inhibits not only matrix metalloproteinase (MMP)-1 expression but also elastase secretion, higher than the effects seen with FGF. Based on these results, we conclude that OP10 plays a role in the regeneration of damaged skin by activating dermal fibroblasts in vitro and may have further potential as wound repair or cosmetic materials for wrinkle improvement.
Similar content being viewed by others
References
SE Lynch, JC Nixon, RB Colvin, et al., Role of plateletderived growth factor in wound healing: synergistic effects with other growth factors, Proc Natl Acad Sci U S A, 84, 7696 (1987).
MA Loot, SB Kenter, FL Au, et al., Fibroblasts derived from chronic diabetic ulcers differ in their response to stimulation with EGF, IGF-I, bFGF and PDGF-AB compared to controls, Eur J Cell Biol, 81, 153 (2002).
L Attisano, JL Wrana, Signal transduction by the TGF-beta superfamily, Science, 296, 1646 (2002).
H Chang, CW Brown, MM Matzuk, Genetic analysis of the mammalian transforming growth factor-beta superfamily, Endocr Rev, 23, 787 (2002).
BL Hogan, Bone morphogenetic proteins in development, Curr Opin Genet Dev, 6, 432 (1996).
DM Kingsley, The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms, Genes Dev, 8, 133 (1994).
MR Urist, BS Strates, Bone morphogenetic protein, J Dent Res, 50, 1392 (1971).
J Moura, L da Silva, MT Cruz, et al., Molecular and cellular mechanisms of bone morphogenetic proteins and activins in the skin: potential benefits for wound healing, Arch Dermatol Res, 305, 557 (2013).
VA Botchkarev, Bone morphogenetic proteins and their antagonists in skin and hair follicle biology, J Invest Dermatol, 120, 36 (2003).
N Hirt-Burri, C Scaletta, S Gerber, et al., Wound-healing gene family expression differences between fetal and foreskin cells used for bioengineered skin substitutes, Artif Organs, 32, 509 (2008).
S Kaiser, P Schirmacher, A Philipp, et al., Induction of bone morphogenetic protein-6 in skin wounds. Delayed reepitheliazation and scar formation in BMP-6 overexpressing transgenic mice, J Invest Dermatol, 111, 1145 (1998).
EA Hwang, HB Lee, KC Tark, Comparison of bone morphogenetic protein receptors expression in the fetal and adult skin, Yonsei Med J, 42, 581 (2001).
M Blessing, P Schirmacher, S Kaiser, Overexpression of bone morphogenetic protein-6 (BMP-6) in the epidermis of transgenic mice: inhibition or stimulation of proliferation depending on the pattern of transgene expression and formation of psoriatic lesions, J Cell Biol, 135, 227 (1996).
M Blessing, LB Nanney, LE King, et al., Chemical skin carcinogenesis is prevented in mice by the induced expression of a TGF-beta related transgene, Teratog Carcinog Mutagen, 15, 11 (1995).
S Wach, P Schirmacher, M Protschka, et al., Overexpression of bone morphogenetic protein-6 (BMP-6) in murine epidermis suppresses skin tumor formation by induction of apoptosis and downregulation of fos/jun family members, Oncogene, 20, 7761 (2001).
I Kurokawa, K Kusumoto, K Bessho, et al., Immunohistochemical expression of bone morphogenetic protein-2 in pilomatricoma, Br J Dermatol, 143, 754 (2000).
JY Lee, JE Choo, YS Choi, et al., Assembly of collagen-binding peptide with collagen as a bioactive scaffold for osteogenesis in vitro and in vivo, Biomaterials, 28, 4257 (2007).
JJ Qian, RS Bhatnagar, Enhanced cell attachment to anorganic bone mineral in the presence of a synthetic peptide related to collagen, J Biomed Mater Res, 31, 545 (1996).
KM Malinda, AB Wysocki, JE Koblinski, et al., Angiogenic laminin-derived peptides stimulate wound healing, Int J Biochem Cell Biol, 40, 2771 (2008).
KP Krafts, Tissue repair: The hidden drama, Organogenesis, 6, 225 (2010).
G Broughton, JE Janis, CE Attinger, The basic science of wound healing, Plast Reconstr Surg, 117, 12S (2006).
SA Eming, T Krieg, JM Davidson, Inflammation in wound repair: molecular and cellular mechanisms, J Invest Dermatol, 127, 514 (2007).
J Stiernberg, AM Norfleet, WR Redin, et al., Acceleration of full-thickness wound healing in normal rats by the synthetic thrombin peptide, TP508, Wound Repair Regen, 8, 204 (2000).
MJ Oudhoff, KL Kroeze, K Nazmi, et al., Structure-activity analysis of histatin, a potent wound healing peptide from human saliva: cyclization of histatin potentiates molar activity 1,000-fold, FASEB J, 23, 3928 (2009).
JM Smiell, TJ Wieman, DL Steed, et al., Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies, Wound Repair Regen, 7, 335 (1999).
T Velnar, T Bailey, V Smrkolj, The wound healing process: an overview of the cellular and molecular mechanisms, J Int Med Res, 37, 1528 (2009).
JM Reinke, H Sorg, Wound repair and regeneration, Eur Surg Res, 49, 35 (2012).
NT Bennett, GS Schultz, Growth factors and wound healing: biochemical properties of growth factors and their receptors, Am J Surg, 165, 728 (1993).
JW Madden, EE Peacock Jr., Studies on the biology of collagen during wound healing 3. Dynamic metabolism of scar collagen and remodeling of dermal wounds, Ann Surg, 174, 511 (1971).
SP Bennett, GD Griffiths, AM Schor, et al., Growth factors in the treatment of diabetic foot ulcers, Br J Surg, 90, 133 (2003).
AH Chang, MT Stephan, L Lisowski, et al., Erythroid-specific human factor IX delivery from in vivo selected hematopoietic stem cells following nonmyeloablative conditioning in hemophilia B mice, Mol Ther, 16, 1745 (2008).
S Even-Ram, KM Yamada, Cell migration in 3D matrix, Curr Opin Cell Biol, 17, 524 (2005).
T Sasaki, The effects of basic fibroblast growth factor and doxorubicin on cultured human skin fibroblasts: relevance to wound healing, J Dermatol, 19, 664 (1992).
BM Hantash, L Zhao, JA Knowles, et al., Adult and fetal wound healing, Front Biosci, 13, 51 (2008).
M van der Rest, R Garrone, Collagen family of proteins, FASEB J, 5, 2814 (1991).
G Fitsialos, AA Chassot, L Turchi, et al., Transcriptional signature of epidermal keratinocytes subjected to in vitro scratch wounding reveals selective roles for ERK1/2, p38, and phosphatidylinositol 3-kinase signaling pathways, J Biol Chem, 282, 15090 (2007).
Y Satoh, D Saitoh, A Takeuchi, et al., ERK2 dependent signaling contributes to wound healing after a partial-thickness burn, Biochem Biophys Res Commun, 381, 118 (2009).
TA Khavari, J Rinn, Ras/Erk MAPK signaling in epidermal homeostasis and neoplasia, Cell Cycle, 6, 2928 (2007).
JD Raffetto, R Vasquez, DG Goodwin, et al., Mitogen-activated protein kinase pathway regulates cell proliferation in venous ulcer fibroblasts, Vasc Endovascular Surg, 40, 59 (2006).
RL Klemke, S Cai, AL Giannini, et al., Regulation of cell motility by mitogen-activated protein kinase, J Cell Biol, 137, 481 (1997).
M Sumitra, P Manikandan, VS Gayathri, et al., Emblica officinalis exerts wound healing action through up-regulation of collagen and extracellular signal-regulated kinases (ERK1/2), Wound Repair Regen, 17, 99 (2009).
KR Cutroneo, Gene therapy for tissue regeneration, J Cell Biochem, 88, 418 (2003).
J Varani, P Perone, SE Fligiel, et al., Inhibition of type I procollagen production in photodamage: correlation between presence of high molecular weight collagen fragments and reduced procollagen synthesis, J Invest Dermatol, 119, 122 (2002).
M Madlener, WC Parks, S Werner, Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair, Exp Cell Res, 242, 201 (1998).
TT Meckmongkol, R Harmon, P McKeown-Longo, et al., The fibronectin synergy site modulates TGF-beta-dependent fibroblast contraction, Biochem Biophys Res Commun, 360, 709 (2007).
M Wankell, B Munz, G Hubner, et al., Impaired wound healing in transgenic mice overexpressing the activin antagonist follistatin in the epidermis, EMBO J, 20, 5361 (2001).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hong, Y., Shim, H., Kim, S. et al. The effects on dermal wound healing using novel peptide modified by bone morphogenic protein-2. Tissue Eng Regen Med 11, 397–404 (2014). https://doi.org/10.1007/s13770-014-0037-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13770-014-0037-4